FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Del Rosso

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Occupations

Dermatology

Living Beings

Propionibacterium acnes

Co-author Network

Publications

TOP 3
James Q Del Rosso; Barry Reece; Kathleen Smith; Terri Miller
Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential.
James Q Del Rosso; Emil Tanghetti
A status report on topical tazarotene in the management of acne vulgaris.
Diane Thiboutot; James Q Del Rosso
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Del Rosso (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James Q Del Rosso; Barry Reece; Kathleen Smith; Terri Miller
Efinaconazole 10% solution: a new topical treatment for onychomycosis: contact sensitization and skin irritation potential.
The Journal of clinical and aesthetic dermatology 2013;6(3):20-4.
2013: James Q Del Rosso; Emil Tanghetti
A status report on topical tazarotene in the management of acne vulgaris.
Journal of drugs in dermatology : JDD 2013;12(3):s53-8.
2013: Diane Thiboutot; James Q Del Rosso
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?
The Journal of clinical and aesthetic dermatology 2013;6(2):18-24.
2013: James Q Del Rosso; Leon H Kircik
The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
Journal of drugs in dermatology : JDD 2013;12(2):s5-s10.
2013: R R Winkelmann; Grace K Kim; James Q Del Rosso
Treatment of Cutaneous Lupus Erythematosus: Review and Assessment of Treatment Benefits Based on Oxford Centre for Evidence-based Medicine Criteria.
The Journal of clinical and aesthetic dermatology 2013;6(1):27-38.
2012: James Q Del Rosso; Leon Kircik
Not all topical corticosteroids are created equal! Optimizing therapeutic outcomes through better understanding of vehicle formulations, compound selection,and methods of application.
Journal of drugs in dermatology : JDD 2012;11(12):s5-8.
2012: Leon H Kircik; James Q Del Rosso
The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
Journal of drugs in dermatology : JDD 2012;11(10):1194-8.
2012: James Q Del Rosso; Leon Kircik
A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.
The Journal of clinical and aesthetic dermatology 2012;5(7):20-4.
2012: Neal D Bhatia; James Q Del Rosso
Optimal management of papulopustular rosacea: rationale for combination therapy.
Journal of drugs in dermatology : JDD 2012;11(7):838-44.
2012: James J Leyden; James Q Del Rosso
The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach.
Journal of drugs in dermatology : JDD 2012;11(7):830-3.
2012: James Q Del Rosso; Scott W Caveney; Norman J Preston; Ronald W Gottschalk
Effectiveness and safety of modified-release doxycycline capsules once daily for papulopustular rosacea monotherapy results from a large community-based trial in subgroups based on gender.
Journal of drugs in dermatology : JDD 2012;11(6):703-7.
2012: James Q Del Rosso; Richard L Gallo; Leon Kircik; Diane Thiboutot; Hilary E Baldwin; David Cohen
Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin.
Journal of drugs in dermatology : JDD 2012;11(6):694-700.
2012: James Q Del Rosso
Message from the guest editor.
Journal of drugs in dermatology : JDD 2012;11(6):692-3.
2012: Grace K Kim; James Q Del Rosso
Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience.
The Journal of clinical and aesthetic dermatology 2012;5(3):37-50.
2012: James Q Del Rosso
Advances in understanding and managing rosacea: part 2: the central role, evaluation, and medical management of diffuse and persistent facial erythema of rosacea.
The Journal of clinical and aesthetic dermatology 2012;5(3):26-36.
2012: James Q Del Rosso
Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema.
The Journal of clinical and aesthetic dermatology 2012;5(3):16-25.
2012: Brent D Michaels; James Q Del Rosso
Tinea capitis in infants: recognition, evaluation, and management suggestions.
The Journal of clinical and aesthetic dermatology 2012;5(2):49-59.
2012: James Q Del Rosso; Julie Harper; Radhakrishnan Pillai; Robert Moore
Tretinoin photostability: comparison of micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to ultraviolet a light.
The Journal of clinical and aesthetic dermatology 2012;5(1):27-9.
2011: James Q Del Rosso; Jacquelyn Levin
Clinical relevance of maintaining the structural and functional integrity of the stratum corneum: why is it important to you?
Journal of drugs in dermatology : JDD 2011;10(10 Suppl):s5-12.
2011: Hyunhee Park; James Q Del Rosso
Use of oral isotretinoin in the management of rosacea.
The Journal of clinical and aesthetic dermatology 2011;4(9):54-61.
2011: James Q Del Rosso; Neal Bhatia
Azelaic acid gel 15% in the management of papulopustular rosacea: a status report on available efficacy data and clinical application.
Cutis; cutaneous medicine for the practitioner 2011;88(2):67-72.
2011: James Q Del Rosso
Current regimens and guideline implications for the treatment of actinic keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology Conference.
Cutis; cutaneous medicine for the practitioner 2011;88(1):suppl 1-8.
2011: James Q Del Rosso
Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin.
The Journal of clinical and aesthetic dermatology 2011;4(6):45-55.
2011: Susun Bellew; Diane Thiboutot; James Q Del Rosso
Pathogenesis of acne vulgaris: what's new, what's interesting and what may be clinically relevant.
Journal of drugs in dermatology : JDD 2011;10(6):582-5.
2011: James Q Del Rosso
Why are dermatologists still talking about acne? Because so many people have it... and we are always seeking better ways to manage it.
Journal of drugs in dermatology : JDD 2011;10(6):575-7.
2011: James Q Del Rosso
Adult seborrheic dermatitis: a status report on practical topical management.
The Journal of clinical and aesthetic dermatology 2011;4(5):32-8.
2011: Leon H Kircik; James Q Del Rosso; Daniel Aversa
Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis.
The Journal of clinical and aesthetic dermatology 2011;4(3):34-40.
2011: James Q Del Rosso
Wound care in the dermatology office: where are we in 2011?
Journal of the American Academy of Dermatology 2011;64(3 Suppl):S1-7.
2011: James J Leyden; James Q Del Rosso
Oral antibiotic therapy for acne vulgaris: pharmacokinetic and pharmacodynamic perspectives.
The Journal of clinical and aesthetic dermatology 2011;4(2):40-7.
2011: Eva Ritvo; Mark A Stillman; James Q Del Rosso; Christopher La Riche
Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations.
BioPsychoSocial medicine 2011;5(1):11.
2010: James Q Del Rosso
Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads) once daily as add-on therapy to existing topical regimens for the treatment of papulopustular rosacea: results from a community-based trial.
Cutis; cutaneous medicine for the practitioner 2010;86(5 Suppl):16-25.
2010: James Q Del Rosso
The ORCA (Oracea for rosacea: a community-based assessment) trial: a large-scale, phase 4 trial in papulopustular rosacea.
Cutis; cutaneous medicine for the practitioner 2010;86(5 Suppl):4-6.
2010: Amylynne J Frankel; Joshua A Zeichner; James Q Del Rosso
Coal tar 2% foam in combination with a superpotent corticosteroid foam for plaque psoriasis: case report and clinical implications.
The Journal of clinical and aesthetic dermatology 2010;3(10):42-5.
2010: James Q Del Rosso; Radhakrishnan Pillai; Robert Moore
Absence of Degradation of Tretinoin When Benzoyl Peroxide is Combined with an Optimized Formulation of Tretinoin Gel (0.05%).
The Journal of clinical and aesthetic dermatology 2010;3(10):26-8.
2010: Joshua A Zeichner; Mark G Lebwohl; Alan Menter; Jerry Bagel; James Q Del Rosso; Boni E Elewski; Steven R Feldman; Leon Kircik; John Koo; Linda Stein Gold; Emil Tanghetti
Optimizing topical therapies for treating psoriasis: a consensus conference.
Cutis; cutaneous medicine for the practitioner 2010;86(3 Suppl):5-31; quiz 32.
2010: Susun Bellew; James Q Del Rosso
Overcoming the Barrier Treatment of Ichthyosis: A Combination-therapy Approach.
The Journal of clinical and aesthetic dermatology 2010;3(7):49-53.
2010: Brent D Michaels; James Q Del Rosso; Narciss Mobini; Jason R Michaels
Erythropoietic protoporphyria: a case report and literature review.
The Journal of clinical and aesthetic dermatology 2010;3(7):44-8.
2010: Susun Bellew; James Q Del Rosso; Narciss Mobini
Hyperkeratotic papular eruptions on legs, arms, and back.
International journal of dermatology 2010;49(7):729-31.
2010: Saira B Momin; Aaron Peterson; James Q Del Rosso
A status report on drug-associated acne and acneiform eruptions.
Journal of drugs in dermatology : JDD 2010;9(6):627-36.
2010: Grace K Kim; James Q Del Rosso
Laser and light-based therapies for acne vulgaris: a current guide based on available data.
Journal of drugs in dermatology : JDD 2010;9(6):614-21.
2010: James Q Del Rosso; Suzanne Bruce; Michael Jarratt; Alan Menter; Gerald Staedtler
Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea.
Journal of drugs in dermatology : JDD 2010;9(6):607-13.
2010: James Q Del Rosso
We are making progress with both acne and rosacea--but, let's face it! We still have a long way to go.
Journal of drugs in dermatology : JDD 2010;9(6):603-4.
2010: Leon Kircik; James Q Del Rosso
Comparative efficacy and safety results of topical hemostatic powder and sterile compressed foam sponge in second intention healing following Mohs micrographic surgery.
Journal of drugs in dermatology : JDD 2010;9(2):137-40.
2010: Grace K Kim; James Q Del Rosso
Drug-provoked psoriasis: is it drug induced or drug aggravated?: understanding pathophysiology and clinical relevance.
The Journal of clinical and aesthetic dermatology 2010;3(1):32-8.
2010: James Q Del Rosso; Nicholas F Schmidt
A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
Cutis; cutaneous medicine for the practitioner 2010;85(1):15-24.
2009: Brent D Michaels; James Q Del Rosso; Saira B Momin
Avoiding the legal "blemish": medicolegal pitfalls in dermatology.
The Journal of clinical and aesthetic dermatology 2009;2(12):35-43.
2009: James Q Del Rosso
Perspectives on seborrheic dermatitis: looking back to move ahead.
Clinics in dermatology 2009;27(6 Suppl):S39-40.
2009: Susun Bellew; James Q Del Rosso; Grace K Kim
Skin cancer in asians: part 2: melanoma.
The Journal of clinical and aesthetic dermatology 2009;2(10):34-6.
2009: James Q Del Rosso; Sanjay Bhambri
Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis.
The Journal of clinical and aesthetic dermatology 2009;2(9):24-32.
2009: James Q Del Rosso; Grace K Kim
Topical antibiotics: therapeutic value or ecologic mischief?
Dermatologic therapy 2009;22(5):398-406.
2009: Grace K Kim; James Q Del Rosso; Susun Bellew
Skin cancer in asians: part 1: nonmelanoma skin cancer.
The Journal of clinical and aesthetic dermatology 2009;2(8):39-42.
2009: Susun Bellew; James Q Del Rosso; Narciss Mobini
Primary carcinosarcoma of the ear: case report and review of the literature.
The Journal of clinical and aesthetic dermatology 2009;2(8):33-5.
2009: James Q Del Rosso
The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris.
The Journal of clinical and aesthetic dermatology 2009;2(8):26-9.
2009: James Q Del Rosso
The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study.
Cutis; cutaneous medicine for the practitioner 2009;84(2):72-6.
2009: James Q Del Rosso
A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on compliance with treatment.
The Journal of clinical and aesthetic dermatology 2009;2(7):26-9.
2009: James Q Del Rosso
Anti-inflamatory dose doxycycline in the treatment of rosacea.
Journal of drugs in dermatology : JDD 2009;8(7):664-8.
2009: Diane M Thiboutot; Alan B Fleischer; James Q Del Rosso; Phoebe Rich
A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Journal of drugs in dermatology : JDD 2009;8(7):639-48.
2009: Sanjay Bhambri; James Q Del Rosso; Avani Bhambri
Pathogenesis of acne vulgaris: recent advances.
Journal of drugs in dermatology : JDD 2009;8(7):615-8.
2009: Avani Bhambri; James Q Del Rosso
Solitary sclerotic fibroma.
The Journal of clinical and aesthetic dermatology 2009;2(6):36-8.
2009: James Q Del Rosso; Hilary Baldwin; Jonette E Keri; Anthony Mancini; Linda Stein Gold; Guy F Webster
Current approach to acne management: a community-based analysis.
Cutis; cutaneous medicine for the practitioner 2009;83(6 Suppl):5-21; quiz 22-4.
2009: James Q Del Rosso; Howard Sofen; Barry Leshin; Tc Meng; James Kulp; Sharon Levy
Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses.
The Journal of clinical and aesthetic dermatology 2009;2(4):20-8.
2009: James Q Del Rosso; Paul A Lehman; Sam G Raney
Impact of order of application of moisturizers on percutaneous absorption kinetics: evaluation of sequential application of moisturizer lotions and azelaic acid gel 15% using a human skin model.
Cutis; cutaneous medicine for the practitioner 2009;83(3):119-24.
2009: Saira B Momin; Blakely S Richardson; Michael G Bryan; James Q Del Rosso; Narciss Mobini
Mycetoma clinically masquerading as squamous cell carcinoma: case report and literature review.
The Journal of clinical and aesthetic dermatology 2009;2(2):26-31.
2009: Joseph B Bikowski; James Q Del Rosso
Demodex dermatitis: a retrospective analysis of clinical diagnosis and successful treatment with topical crotamiton.
The Journal of clinical and aesthetic dermatology 2009;2(1):20-5.
2009: James Q Del Rosso
Oral antibiotic drug interactions of clinical significance to dermatologists.
Dermatologic clinics 2009;27(1):91-4.
2009: Sanjay Bhambri; Avani Bhambri; James Q Del Rosso
Atypical mycobacterial cutaneous infections.
Dermatologic clinics 2009;27(1):63-73.
2009: James Q Del Rosso; Grace Kim
Optimizing use of oral antibiotics in acne vulgaris.
Dermatologic clinics 2009;27(1):33-42.
2009: James J Leyden; James Q Del Rosso; Guy F Webster
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: a status report.
Dermatologic clinics 2009;27(1):1-15.
2008: James Q Del Rosso; Sanjay Bhambri; Brent Michaels
An Aluminum Magnesium Hydroxide Stearate-based Skin Barrier Protection Cream Used for the Management of Eczematous Dermatitis: A Summary of Completed Studies.
The Journal of clinical and aesthetic dermatology 2008;1(4):18-21.
2008: James Q Del Rosso
Selection of therapy for acne vulgaris: balancing concerns about antibiotic resistance.
Cutis; cutaneous medicine for the practitioner 2008;82(5 Suppl):12-6.
2008: Lawrence J Green; James Q Del Rosso
Efficacy and Tolerability of a Three-Step Acne System Containing a Solubilized Benzoyl Peroxide Lotion versus a Benzoyl Peroxide/Clindamycin Combination Product: An Investigator-Blind, Randomized, Parallel-Group Study.
The Journal of clinical and aesthetic dermatology 2008;1(3):16-20.
2008: James Q Del Rosso
Update from the Scientific Panel on Antibiotic Use in Dermatology: clinical considerations for the dermatologist.
Cutis; cutaneous medicine for the practitioner 2008;82(2 Suppl 2):3-4.
2008: James Q Del Rosso; James J Leyden; Diane M Thiboutot; Guy F Webster
Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists.
Cutis; cutaneous medicine for the practitioner 2008;82(2 Suppl 2):5-12.
2008: Avani Bhambri; James Q Del Rosso
Calciphylaxis: a review.
The Journal of clinical and aesthetic dermatology 2008;1(2):38-41.
2008: James Q Del Rosso
Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate.
Cutis; cutaneous medicine for the practitioner 2008;81(6 Suppl):4-18; quiz 19-20.
2008: James Q Del Rosso
Journal of Drugs in Dermatology: New methods and Techniques. Managing acne with adapalene 0.1% and 0.3% gels. Introduction.
Journal of drugs in dermatology : JDD 2008;7(6 Suppl):s2.
2008: Joseph Bikowski; James Q Del Rosso
Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
Journal of drugs in dermatology : JDD 2008;7(6):590-5.
2008: James Q Del Rosso; Joel Schlessinger; Philip Werschler
Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.
Journal of drugs in dermatology : JDD 2008;7(6):573-6.
2008: Diane M Thiboutot; Alan B Fleischer; James Q Del Rosso; Klaus Graupe
Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea.
Journal of drugs in dermatology : JDD 2008;7(6):541-6.
2008: James Q Del Rosso; Hilary Baldwin; Guy Webster
American Acne & Rosacea Society rosacea medical management guidelines.
Journal of drugs in dermatology : JDD 2008;7(6):531-3.
2008: James Q Del Rosso
Acne and rosacea.
Journal of drugs in dermatology : JDD 2008;7(6):525.
2008: Sanjay Bhambri; Avani Desai; James Q Del Rosso; Narciss Mobini
Dermatofibrosarcoma protuberans: a case report and review of the literature.
The Journal of clinical and aesthetic dermatology 2008;1(1):34-6.
2008: James Q Del Rosso; Eric W Baum
Comprehensive medical management of rosacea: an interim study report and literature review.
The Journal of clinical and aesthetic dermatology 2008;1(1):20-5.
2008: James Q Del Rosso; Waranush Jitpraphai; Sanjay Bhambri; Saira Momin
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
Cutis; cutaneous medicine for the practitioner 2008;81(5):405-8.
2008: James Q Del Rosso; Joseph Bikowski
Trolamine-containing topical emulsion: clinical applications in dermatology.
Cutis; cutaneous medicine for the practitioner 2008;81(3):209-14.
2008: Michael Romanowicz; Judith J Stephenson; James Q Del Rosso; Greg Lenhart
Healthcare utilization and costs of patients with rosacea in an insured population.
Journal of drugs in dermatology : JDD 2008;7(1):41-9.
2007: James Q Del Rosso
Newer topical therapies for the treatment of acne vulgaris.
Cutis; cutaneous medicine for the practitioner 2007;80(5):400-10.
2007: James Q Del Rosso
Recently approved systemic therapies for acne vulgaris and rosacea.
Cutis; cutaneous medicine for the practitioner 2007;80(2):113-20.
2007: Sanjay Bhambri; James Q Del Rosso; Avani Desai
Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.
Cutis; cutaneous medicine for the practitioner 2007;79(6):430-4.
2007: James Q Del Rosso
Updates & perspectives on management of common dermatologic disorders.
Journal of drugs in dermatology : JDD 2007;6(6):662-4.
2007: James Q Del Rosso
Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
Journal of drugs in dermatology : JDD 2007;6(6):616-22.
2007: James Q Del Rosso; Joseph B Bikowski; Eric Baum; Jason Smith; Steve Hawkes; Vanessa Benes; Neal Bhatia
A closer look at truncal acne vulgaris: prevalence, severity, and clinical significance.
Journal of drugs in dermatology : JDD 2007;6(6):597-600.
2007: James Q Del Rosso; Dirk M Elston
Tackling the anterior nares and other sites of colonization: implications for the dermatologist.
Cutis; cutaneous medicine for the practitioner 2007;79(6 Suppl):52-9.
2007: James J Leyden; James Q Del Rosso; Guy F Webster
Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
Cutis; cutaneous medicine for the practitioner 2007;79(6 Suppl):9-25.
2007: James Q Del Rosso; Guy F Webster; Mark Jackson; Marta Rendon; Phoebe Rich; Helen Torok; Mark Bradshaw
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea.
Journal of the American Academy of Dermatology 2007;56(5):791-802.
2007: James Q Del Rosso
The treatment of viral infections and nonmelanoma skin cancers.
Cutis; cutaneous medicine for the practitioner 2007;79(4 Suppl):29-35.
2007: Alpesh Desai; Francisca Kartono; James Q Del Rosso
Systemic retinoid therapy: a status report on optimal use and safety of long-term therapy.
Dermatologic clinics 2007;25(2):185-93, vi.
2007: Guy Webster; James Q Del Rosso
Anti-inflammatory activity of tetracyclines.
Dermatologic clinics 2007;25(2):133-5, v.
2007: James Q Del Rosso; James J Leyden
Status report on antibiotic resistance: implications for the dermatologist.
Dermatologic clinics 2007;25(2):127-32, v.
2007: James Q Del Rosso; Zoe Diana Draelos; Joseph L Jorizzo; Warren S Joseph; Bret Ribotsky; Phoebe Rich
Modern methods to treat superficial fungal disease.
Cutis; cutaneous medicine for the practitioner 2007;79(2 Suppl):6-29.
2007: James Q Del Rosso
Truncal acne vulgaris: the relative roles of topical and systemic antibiotic therapy.
Journal of drugs in dermatology : JDD 2007;6(2):148-51.
2007: John E Wolf; James Q Del Rosso
The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.
Cutis; cutaneous medicine for the practitioner 2007;79(1):73-80.
2006: James Q Del Rosso; Eric W Baum; Zoe Diana Draelos; Boni E Elewski; Alan B Fleischer; Lenore S Kakita; Diane M Thiboutot
Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.
Cutis; cutaneous medicine for the practitioner 2006;78(5 Suppl):6-19.
2006: James Q Del Rosso
Therapeutic experience with cefdinir in the treatment of uSSSIs.
International journal of clinical practice 2006;60(10):1313-6.
2006: Joseph B Bikowski; Valerie D Callender; James Q Del Rosso; Zoe Diana Draelos; Emil Tanghetti
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Cutis; cutaneous medicine for the practitioner 2006;78(2 Suppl 1):13-20.
2006: James Q Del Rosso
Combination topical therapy in the treatment of acne.
Cutis; cutaneous medicine for the practitioner 2006;78(2 Suppl 1):5-12.
2006: James Q Del Rosso
Defining criteria used to evaluate response to treatment of acne vulgaris.
Cutis; cutaneous medicine for the practitioner 2006;78(2):117-21.
2006: James Q Del Rosso
Update on rosacea pathogenesis and correlation with medical therapeutic agents.
Cutis; cutaneous medicine for the practitioner 2006;78(2):97-100.
2006: James Q Del Rosso
Management of truncal acne vulgaris: current perspectives on treatment.
Cutis; cutaneous medicine for the practitioner 2006;77(5):285-9.
2006: Roger I Ceilley; James Q Del Rosso
Current modalities and new advances in the treatment of basal cell carcinoma.
International journal of dermatology 2006;45(5):489-98.
2006: James Q Del Rosso
Clinical significance of brand versus generic formulations: focus on oral minocycline.
Cutis; cutaneous medicine for the practitioner 2006;77(3):153-6.
2006: James Q Del Rosso
The use of topical azelaic acid for common skin disorders other than inflammatory rosacea.
Cutis; cutaneous medicine for the practitioner 2006;77(2 Suppl):22-4.
2006: James Q Del Rosso; Emil Tanghetti
The clinical impact of vehicle technology using a patented formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin tolerability and evaluation of combination use with a topical retinoid.
Journal of drugs in dermatology : JDD 2006;5(2):160-4.
2005: James Q Del Rosso
The use of topical imiquimod for the treatment of actinic keratosis: a status report.
Cutis; cutaneous medicine for the practitioner 2005;76(4):241-8.
2005: James Q Del Rosso
A qualitative and quantitative assessment of the application and use of topical acne medication by patients.
Cutis; cutaneous medicine for the practitioner 2005;76(2):109-13.
2005: James Q Del Rosso
The role of the vehicle in combination acne therapy.
Cutis; cutaneous medicine for the practitioner 2005;76(2 Suppl):15-8.
2005: James Q Del Rosso; Joseph B Bikowski
Topical metronidazole combination therapy in the clinical management of rosacea.
Journal of drugs in dermatology : JDD 2005;4(4):473-80.
2005: James Q Del Rosso; Sheila Fallon Friedlander
Corticosteroids: options in the era of steroid-sparing therapy.
Journal of the American Academy of Dermatology 2005;53(1 Suppl 1):S50-8.
2005: James Q Del Rosso
Antibiotic resistance: overview and significance in dermatology.
Cutis; cutaneous medicine for the practitioner 2005;75(4 Suppl):12-8.
2005: James Q Del Rosso
Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and photoprotectants.
Cutis; cutaneous medicine for the practitioner 2005;75(3 Suppl):17-21; discussion 33-6.
2004: Dina N Anderson; Valerie D Callender; James Q Del Rosso; Emil Tanghetti; Lee T Zane
Topical tazarotene in acne vulgaris: treatment approaches.
Cutis; cutaneous medicine for the practitioner 2004;74(4 Suppl):16-21.
2004: James Q Del Rosso
Topical retinoids in the management of acne: the best path to clear results.
Cutis; cutaneous medicine for the practitioner 2004;74(4 Suppl):2-3.
2004: James Q Del Rosso
A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines.
Cutis; cutaneous medicine for the practitioner 2004;74(2):118-22.
2004: James Q Del Rosso; John E Wolf; James Leyden; Larry E Millikan; Richard B Odom; Alan R Shalita
The treatment of rosacea.
Cutis; cutaneous medicine for the practitioner 2004;73(1 Suppl):34-6.
2004: James Q Del Rosso
Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations.
Cutis; cutaneous medicine for the practitioner 2004;73(1 Suppl):29-33.
2004: James Q Del Rosso
Medical treatment of rosacea with emphasis on topical therapies.
Expert opinion on pharmacotherapy 2004;5(1):5-13.
2003: James Q Del Rosso
New and emerging topical approaches for actinic keratoses.
Cutis; cutaneous medicine for the practitioner 2003;72(4):273-6, 279.
2003: James Q Del Rosso
Oral cephalosporin antibiotics: an overview of clinical pharmacology and dermatologic applications.
Cutis; cutaneous medicine for the practitioner 2003;71(2):153-7.
2003: James Q Del Rosso
An update on newer topical therapies for actinic keratoses: advances and applications.
Journal of drugs in dermatology : JDD 2003;2(1):35-9.
2003: James Q Del Rosso
Cephalosporins in dermatology.
Clinics in dermatology 2003;21(1):24-32.
2002: James Q Del Rosso
A status report on the medical management of rosacea: focus on topical therapies.
Cutis; cutaneous medicine for the practitioner 2002;70(5):271-5.
2002: James Q Del Rosso
Retinoic acid receptors and topical acne therapy: establishing the link between gene expression and drug efficacy.
Cutis; cutaneous medicine for the practitioner 2002;70(2):127-9.
2002: James Q Del Rosso
Skin manifestations of drug reactions.
Current allergy and asthma reports 2002;2(4):282-7.
2000: James Q Del Rosso
Systemic therapy for rosacea: focus on oral antibiotic therapy and safety.
Cutis; cutaneous medicine for the practitioner 2000;66(4 Suppl):7-13.
1999: James Q Del Rosso; A K Gupta
The use of intermittent itraconazole therapy for superficial mycotic infections: a review and update on the 'one week' approach.
International journal of dermatology 1999;38 Suppl 2():28-39.
1999: James Q Del Rosso; AK Gupta
Management of tinea capitis. A status report.
Postgraduate medicine 1999;Spec No():38-45.
1998: James Q Del Rosso; S Zellis; AK Gupta
Itraconazole in the treatment of superficial cutaneous and mucosal Candida infections.
The Journal of the American Osteopathic Association 1998;98(9):497-502.